# Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

> **NCT00003029** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 200 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00003029
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** 2003-07
- **Final completion:** —
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003029, "Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*